Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Salvetti

Showing results (111-120 of 231) with videos related to

Pageof 24
Sort By:
Annali Dell'Istituto Superiore Di Sanita|October 26, 2005
Quantification of chemical elements in blood of patients affected by multiple sclerosisGiovanni Forte, Andrea Visconti, Simone Santucci, et al.
Journal of Neuroinflammation|July 30, 2013
Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosisFrancesco Lolli, Helene Martini, Alessandra Citro, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 21, 2020
EBV-specific CD8 T lymphocytes and B cells during glatiramer acetate therapy in patients with MSGisella Guerrera, Serena Ruggieri, Mario Picozza, et al.
Dementia and Geriatric Cognitive Disorders|April 26, 2003
T cell response to amyloid-beta and to mitochondrial antigens in Alzheimer's diseaseFranco Giubilei, Giovanni Antonini, Chiara Montesperelli, et al.
Frontiers in Immunology|September 27, 2019
The Contribution of Gut Barrier Changes to Multiple Sclerosis PathophysiologyMaria Chiara Buscarinu, Arianna Fornasiero, Silvia Romano, et al.
Journal of Neuropathology and Experimental Neurology|April 24, 2008
Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-betaRoberto Lande, Valérie Gafa, Barbara Serafini, et al.
Current Neuropharmacology|September 16, 2024
Disease-Modifying Symptomatic Treatment (DMST) Potential of Cannabinoids in Patients with Multiple SclerosisAntonio Bruno, Pietro Annovazzi, Marinella Clerico, et al.
F1000Research|January 18, 2021
SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targetsGianmarco Bellucci, Chiara Ballerini, Rosella Mechelli, et al.
Autoimmunity|March 17, 2007
Gene expression profiles reveal homeostatic dynamics during interferon-beta therapy in multiple sclerosisViviana Annibali, Simone Di Giovanni, Stefania Cannoni, et al.
Immunology Letters|January 14, 2014
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytesCristina Camperio, Michela Muscolini, Elisabetta Volpe, et al.
Pageof 24

Showing results (111-120 of 231) with videos related to

Sort By:
Pageof 24
Annali Dell'Istituto Superiore Di Sanita|October 26, 2005
Quantification of chemical elements in blood of patients affected by multiple sclerosisGiovanni Forte, Andrea Visconti, Simone Santucci, et al.
Journal of Neuroinflammation|July 30, 2013
Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosisFrancesco Lolli, Helene Martini, Alessandra Citro, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 21, 2020
EBV-specific CD8 T lymphocytes and B cells during glatiramer acetate therapy in patients with MSGisella Guerrera, Serena Ruggieri, Mario Picozza, et al.
Dementia and Geriatric Cognitive Disorders|April 26, 2003
T cell response to amyloid-beta and to mitochondrial antigens in Alzheimer's diseaseFranco Giubilei, Giovanni Antonini, Chiara Montesperelli, et al.
Frontiers in Immunology|September 27, 2019
The Contribution of Gut Barrier Changes to Multiple Sclerosis PathophysiologyMaria Chiara Buscarinu, Arianna Fornasiero, Silvia Romano, et al.
Journal of Neuropathology and Experimental Neurology|April 24, 2008
Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-betaRoberto Lande, Valérie Gafa, Barbara Serafini, et al.
Current Neuropharmacology|September 16, 2024
Disease-Modifying Symptomatic Treatment (DMST) Potential of Cannabinoids in Patients with Multiple SclerosisAntonio Bruno, Pietro Annovazzi, Marinella Clerico, et al.
F1000Research|January 18, 2021
SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targetsGianmarco Bellucci, Chiara Ballerini, Rosella Mechelli, et al.
Autoimmunity|March 17, 2007
Gene expression profiles reveal homeostatic dynamics during interferon-beta therapy in multiple sclerosisViviana Annibali, Simone Di Giovanni, Stefania Cannoni, et al.
Immunology Letters|January 14, 2014
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytesCristina Camperio, Michela Muscolini, Elisabetta Volpe, et al.
Pageof 24